Ricerca

Pubblicazioni IRIS

• JAK2 is a critical therapeutic target in VEXAS syndrome treated with ruxolitinib
  Anno: 2025
• Complete pathological response of hormone receptor positive invasive breast cancer in a patient with multiple myeloma treated with ixazomib
  Anno: 2023